C-IAP1 binds and processes PCSK9 protein: Linking the c-IAP1 in a TNF-α pathway to PCSK9-mediated LDLR degradation pathway

Molecules

Volumn 17, Issue 10, 2012, Pages 12086-12101

  Xu, Weiming ^a,b   Liu, Lizhi ^a   Hornby, David ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b London Biotech Ltd   (United Kingdom)

Author keywords

c IAP1; Cholesterol; E3 ligase; K27; LDLR; PCSK9; Stub1; TNF ; Ubiquitination

Indexed keywords

CARRIER PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PCSK9 PROTEIN, HUMAN; SERINE PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL LINE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEOMICS; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; CELL LINE; GENE KNOCKDOWN TECHNIQUES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; PROPROTEIN CONVERTASES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEOLYSIS; PROTEOMICS; RECEPTORS, LDL; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868150027     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171012086     Document Type: Article

References (30)

1. Abifadel, M.; Varret, M.; Rabes, J.P.; Allard, D.; Ouguerram, K.; Devillers, M.; Cruaud, C.; Benjannet, S.; Wickham, L.; Erlich, D.; et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 2003, 34, 154-156.
2. Maxwell, K.N.; Breslow, J.L. Proprotein convertase subtilisin kexin 9: The third locus implicated in autosomal dominant hypercholesterolemia. Curr. Opin. Lipidol. 2005, 16, 167-172.
3. Cohen, J.C.; Boerwinkle, E.; Mosley, T.H., Jr.; Hobbs, H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 2006, 354, 1264-1272.
4. Costet, P.; Krempf, M.; Cariou, B. PCSK9 and LDL cholesterol: Unravelling the target to design the bullet. Trends Biochem. Sci. 2008, 33, 426-434.
5. Horton, J.D.; Cohen, J.C.; Hobbs, H.H. Molecular biology of PCSK9: Its role in LDL metabolism. Trends Biochem. Sci. 2007, 32, 71-77.
6. Seidah, N.G.; Prat, A. The proprotein convertases are potential targets in the treatment of dyslipidemia. J. Mol. Med. 2007, 85, 685-696.
7. Poirier, S.; Mayer, G.; Benjannet, S.; Bergeron, E.; Marcinkiewicz, J.; Nassoury, N.; Mayer, H.; Nimpf, J.; Prat, A.; Seidah, N.G. The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2. J. Biol. Chem. 2008, 283, 2363-2372.
8. Park, S.W.; Moon, Y.A.; Horton, J.D. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J. Biol. Chem. 2004, 279, 50630-50638.
9. Liu, H.; Sadygov, R.G.; Yates, J.R., 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
10. Li, X.; Yang, Y.; Ashwell, J.D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002, 416, 345-347.
11. Vince, J.E.; Wong, W.W.; Khan, N.; Feltham, R.; Chau, D.; Ahmed, A.U.; Benetatos, C.A.; Chunduru, S.K.; Condon, S.M.; McKinlay, M.; et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007, 131, 682-693.
12. Kamitani, T.; Kito, K.; Nguyen, H.P.; Yeh, E.T. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J. Biol. Chem. 1997, 272, 28557-28562.
13. Denis, N.J.; Vasilescu, J.; Lambert, J.P.; Smith, J.C.; Figeys, D. Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry. Proteomics 2007, 7, 868-874.
14. Lagace, T.A.; Curtis, D.E.; Garuti, R.; McNutt, M.C.; Park, S.W.; Prather, H.B.; Anderson, N.N.; Ho, Y.K.; Hammer, R.E.; Horton, J.D. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J. Clin. Invest. 2006, 116, 2995-3005.
15. Ikeda, H.; Kerppola, T.K. Lysosomal localization of ubiquitinated Jun requires multiple determinants in a lysine-27-linked polyubiquitin conjugate. Mol. Biol. Cell 2008, 19, 4588-4601.
16. Wu, C.J.; Conze, D.B.; Li, X.; Ying, S.X.; Hanover, J.A.; Ashwell, J.D. TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J. 2005, 24, 1886-1898.
17. Vince, J.E.; Chau, D.; Callus, B.; Wong, W.W.; Hawkins, C.J.; Schneider, P.; McKinlay, M.; Benetatos, C.A.; Condon, S.M.; Chunduru, S.K.; et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J. Cell Biol. 2008, 182, 171-184.
18. Afshar, N.; Black, B.E.; Paschal, B.M. Retrotranslocation of the chaperone calreticulin from the endoplasmic reticulum lumen to the cytosol. Mol. Cell Biol. 2005, 25, 8844-8853.
19. Mousavi, S.A.; Berge, K.E.; Leren, T.P. The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis. J. Intern. Med. 2009, 266, 507-519.
20. Choi, Y.E.; Butterworth, M.; Malladi, S.; Duckett, C.S.; Cohen, G.M.; Bratton, S.B. The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and-7 via unique mechanisms at distinct steps in their processing. J. Biol. Chem. 2009, 284, 12772-12782.
21. Ghribi, O.; Herman, M.M.; Savory, J. The endoplasmic reticulum is the main site for caspase-3 activation following aluminum-induced neurotoxicity in rabbit hippocampus. Neurosci. Lett. 2002, 324, 217-221.
22. McNutt, M.C.; Lagace, T.A.; Horton, J.D. Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells. J. Biol. Chem. 2007, 282, 20799-20803.
23. Pandit, S.; Wisniewski, D.; Santoro, J.C.; Ha, S.; Ramakrishnan, V.; Cubbon, R.M.; Cummings, R.T.; Wright, S.D.; Sparrow, C.P.; Sitlani, A.; et al. Functional analysis of sites within PCSK9 responsible for hypercholesterolemia. J. Lipid Res. 2008, 49, 1333-1343.
24. Kwon, H.J.; Lagace, T.A.; McNutt, M.C.; Horton, J.D.; Deisenhofer, J. Molecular basis for LDL receptor recognition by PCSK9. Proc. Natl. Acad. Sci. USA 2008, 105, 1820-1825.
25. Ballinger, C.A.; Connell, P.; Wu, Y.; Hu, Z.; Thompson, L.J.; Yin, L.Y.; Patterson, C. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell Biol. 1999, 19, 4535-4545.
26. Welchman, R.L.; Gordon, C.; Mayer, R.J. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Biol. 2005, 6, 599-609.
27. Zelcer, N.; Hong, C.; Boyadjian, R.; Tontonoz, P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009, 325, 100-104.
28. Xu, W.; Liu, L.; Charles, I.G.; Moncada, S. Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum stress response. Nat. Cell Biol. 2004, 6, 1129-1134.
29. Xu, W.; Liu, L.; Brown, N.J.; Christian, S.; Hornby, D. Quantum dot-conjugated anti-GRP78 scFv inhibits cancer growth in mice. Molecules 2012, 17, 796-808.
30. Livingston, C.M.; Ifrim, M.F.; Cowan, A.E.; Weller, S.K. Virus-Induced Chaperone-Enriched (VICE) domains function as nuclear protein quality control centers during HSV-1 infection. PLoS Pathog. 2009, 5, e1000619.